WCPO: Study for opioid addiction treatment during pregnancy

UC study is seeking participants in treatment study for pregnant mothers fighting addiction

UC is seeking participants for a study looking at an opioid addiction treatment that could weaken withdrawal symptoms and increase the likelihood of recovery.

What makes this study different is that participants must be women who are pregnant.

Addiction treatments for pregnant women can be difficult to advance due to concerns about testing during the pregnancy. UC researchers hope this study can move the needle.

"Medicine is not typically tested on pregnant women, because we like to be extra careful," said Christine Wilder, MD, associate professor and medical director of the Addiction Sciences Division in the Department of Psychiatry and Behavioral Neuroscience at UC and a UC Health physician. "So if we have a treatment that we know might be more effective, but it's not actually been tested in pregnant women, people tend not to want to use it."

Wilder, who is leading the study, and her team have embarked on a 20-month study. The drug they're studying, buprenorphine, isn't new, but the way test subjects are taking it is. The drug is usually administered daily under the tongue, but this method is known to produce side effects that sometimes outweigh the intended benefit.

The study, funded by the National Institutes of Health, will examine the drug's effectiveness when injected on a weekly basis and will administer the injections for 25 women from the Tristate area along with another 300 from around the U.S.

Watch the full WCPO report.

Read more about the study and how to participate on the UC News website.

Featured photo of Christine Wilder in her clinic by Colleen Kelley/UC Creative + Brand.

Impact Lives Here

The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.

Stay up on all UC's COVID-19 stories, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.

Related Stories

1

Sugar overload killing hearts

November 10, 2025

Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.

2

Is going nuclear the solution to Ohio’s energy costs?

November 10, 2025

The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.

3

App turns smartwatch into detector of structural heart disease

November 10, 2025

An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.